Loading stock data…
10x Genomics, Inc. (TXG)
$37.15+0.40 (+1.09%)
Market ClosedLast close Jun 29
10x Genomics, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
10x Genomics, Inc. in the Healthcare sector is trading at $37.15 with a market capitalization of $4.1B. Wall Street consensus targets $27.62 (13 analysts), implying a -25.7% move over the next 12 months. The stock is currently near its 52-week high of $37.49, remaining 88.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -25.7% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $150.84M↓ | $166.03M↑ | $149.00M↓ | $172.91M↑ | $154.88M |
| Gross Profit | $106.18M↓ | $113.05M↑ | $100.31M↓ | $125.08M↑ | $105.44M |
| Operating Income | -$17.05M↑ | -$19.54M↑ | -$32.24M↓ | -$10.57M↑ | -$48.53M |
| Net Income | -$13.47M↑ | -$16.25M↑ | -$27.47M↓ | $34.54M↑ | -$34.36M |
Peer Comparison
JNJUNHPFE
Fundamentals
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.08B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.05
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.78%
Volume
Today's trading volume
2.68M
Recent News
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor
Check out the companies making headlines this week:
Why Is 10x Genomics (TXG) Stock Soaring Today
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6.8% in the morning session after Barclays boosted its price target to $40 per share and maintained an Overweight rating on the stock.
10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics
TXG collaborates with the Cleveland Clinic to advance bladder cancer diagnostics using Flex Apex, Xenium and potentially Atera.
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?
The past six months have been a windfall for 10x Genomics’s shareholders. The company’s stock price has jumped 116%, setting a new 52-week high of $34.69 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Cathie Wood Cleans House: Another Day Of Heavy Sales
Monday's sales follow a major liquidation last week that was used to fund purchases of SpaceX stock.